← Back
$ANTX All transactions

AN2 Therapeutics, Inc.

A

$ Value

$0

Shares

100,000

Price

$0

Filed

Feb 23

Insider

Name

Eizen Joshua M

Title

See Remarks

CIK

0001949621

Roles

Officer

Transaction Details

Transaction Date

2026-02-20

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

100,000

Footnotes

Represents restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2026, subject to the Reporting Person's continuous service through each applicable vesting date. | Includes a balance of (a) 30,000 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2024, (b) 60,000 RSUs which vest as follows: 25% of the RSUs vest on January 1, 2025, 50% of the RSUs vest on January 1, 2026, and 25% of the RSUs vest on July 1, 2026, (c) 31,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024, and (d) 58,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2025, in each case subject to the Reporting Person's continuous service through each applicable vesting date. | Reflects the adjusted total which includes the purchase of 5,000 shares under the Issuer's 2022 Employee Stock Purchase Plan on March 31, 2025. | The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

Filing Info

Accession No.

0001193125-26-064176

Form Type

4

Issuer CIK

0001880438

Eizen Joshua M's History

Date Ticker Type Value
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-02-20 ANTX A $0
2026-02-20 ANTX A $0
2026-01-06 ANTX $7K
2026-01-05 ANTX $18K
2025-11-04 ANTX $3K

Other Insiders at ANTX (90d)

Insider Bought Sold Last
Zakrzewski Joseph S 2026-03-19
Spigelman Melvin K 2026-03-19
Wong Stephanie 2026-03-19
Chanda Sanjay
Chief Development Officer
2026-03-19
FitzPatrick Margaret M 2026-03-19
Easom Eric
Chief Executive Officer
2026-03-19
Day Lucy
Chief Financial Officer
2026-03-19
Aziz Kabeer 2026-04-10
Readnour Robin Shane 2026-03-19
Martin Patricia A. 2026-04-10
Marks Gilbert Lynn 2026-04-10
Eizen Joshua M
See Remarks
2026-03-19
Williams Sarah Joanne
Principal Accounting Officer
$347 2026-03-03